⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1249337 | 0.83 | TPI1 (0.40) | — | |
| Phosphoric Acid SCHEMBL22469981 | 0.80 | TPI1 (0.39) | — | |
| SCHEMBL21332809 | 0.78 | ALDH1A1 (0.46) | — | |
| SCHEMBL837780 | 0.77 | — | — | |
| SCHEMBL533763 | 0.76 | FDPS (0.44) | — | |
| SCHEMBL27844425 | 0.75 | TPI1 (0.39) | — | |
| Phosphoric Acid SCHEMBL27449329 | 0.75 | TPI1 (0.39) | — | |
| SCHEMBL28235921 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL30771982 | 0.75 | — | — | |
| SCHEMBL28237023 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4364727-A2 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | Teon Therapeutics, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-3762386-B1 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | TEON THERAPEUTICS INC (US) | 2024-01-24 | — | — | EP | disclosed |
| CN-112218867-B | Adenosine receptor antagonists and uses thereof | 泰昂治疗公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20220056033-A1 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | TEON THERAPEUTICS, INC. | 2022-02-24 | — | — | US | disclosed |
| US-11124515-B2 | Adenosine receptor antagonists and uses thereof | TEON THERAPEUTICS, INC. (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210163483-A1 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | TEON THERAPEUTICS, INC. | 2021-06-03 | — | — | US | disclosed |
| US-20210040097-A1 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | TEON THERAPEUTICS, INC. | 2021-02-11 | — | — | US | disclosed |
| EP-3762386-A1 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | Teon Therapeutics, Inc. (US) | 2021-01-13 | — | — | EP | disclosed |
| CN-112218867-A | Adenosine receptor antagonists and uses thereof | 泰昂治疗公司 | 2021-01-12 | — | — | CN | disclosed |
| WO-2019173380-A1 | ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF | TEON THERAPEUTICS, INC. (US) | 2019-09-12 | — | — | WO | disclosed |